Question 1

What are the potential side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants clinical trial (NCT05418868). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will I need to come in for visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants clinical trial (NCT05418868). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the injection process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants clinical trial (NCT05418868). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants clinical trial (NCT05418868). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial contribute to understanding HIV treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants clinical trial (NCT05418868). Contact the study team or your healthcare provider for specific answers.

What this study is about